- Correction
- Open Access
- Published:
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
BMC Cancer volume 19, Article number: 492 (2019)
Correction to: BMC Cancer, 2019; 19:397
https://doi.org/10.1186/s12885-019-5544-1
Following publication of the original article [1], the authors reported that an error in the Methods/Design, Study design and objectives section (third sentence). The dose of “50.4Gy/2.14Gy/28f” is incorrect and should be “50.4Gy/1.80Gy/28f”.
The sentence should read: The technique of SIB is adopted in this study with a dose of 50.4Gy/1.80Gy/28f to planning target volume (PTV) and 59.92Gy/2.14Gy/28f to planning gross tumor volume (PGTV).
The authors apologise for the inconvenience caused.
Reference
Li, et al. A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol. BMC Cancer. 2019;19:397 https://doi.org/10.1186/s12885-019-5544-1.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Li, C., Wang, X., Wang, X. et al. Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol. BMC Cancer 19, 492 (2019). https://doi.org/10.1186/s12885-019-5699-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-019-5699-9